Previous Article | Next Article 
Infection and Immunity, August 2001, p. 4782-4789, Vol. 69, No. 8
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.4782-4789.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Potential Virulence Role of the Legionella
pneumophila ptsP Ortholog
Futoshi
Higa1,2 and
Paul H.
Edelstein1,3,*
Department of Pathology and Laboratory
Medicine1 and Department of
Medicine,3 University of Pennsylvania
Medical School, Philadelphia, PA 19104-4283, and First
Department of Internal Medicine, Faculty of Medicine, University of
the Ryukyus, Okinawa 903-0215, Japan2
Received 26 October 2000/Returned for modification 5 February
2001/Accepted 2 May 2001
 |
ABSTRACT |
We previously identified the Legionella pneumophila
ptsP (phosphoenolpyruvate phosphotransferase) ortholog gene as a
putative virulence factor in a study of signature-tagged mutagenesis
using a guinea pig pneumonia model. In this study, we further defined the phenotypic properties of L. pneumophila ptsP and its
complete sequence. The L. pneumophila ptsP was 2,295 bases
in length. Its deduced amino acid sequence had high similarity with
ptsP orthologs of Pseudomonas aeruginosa, Azotobacter
vinelandii, and Escherichia coli, with nearly
identical lengths. Here we show that while the mutant grew well in
laboratory media, it was defective in both lung and spleen
multiplication in guinea pigs. It grew slowly in guinea pig alveolar
macrophages despite good uptake into the cells. Furthermore, there was
minimal growth in a human alveolar epithelial cell line (A549).
Transcomplementation of the L. pneumophila ptsP mutant
almost completely rescued its growth in alveolar macrophages, in A549
cells, and in guinea pig lung and spleen. The L. pneumophila ptsP mutant was capable of evasion of phagosome-lysosome fusion and resided in ribosome-studded phagosomes. Pore formation activity of
the mutant was normal. The L. pneumophila ptsP mutant
expressed DotA and IcmX in apparently normal amounts, suggesting that
the ptsP mutation did not affect dotA and
icmX regulation. In addition, the mutant was resistant to
serum and neutrophil killing. Taken together, these findings show that
L. pneumophila ptsP is required for full in vivo virulence
of L. pneumophila, most probably by affecting intracellular growth.
 |
INTRODUCTION |
Legionella pneumophila is
the most common etiologic agent of Legionnaires' disease, a type of
pneumonia affecting immunocompromised and immunocompetent humans
(13). This gram-negative bacterium is a facultative
intracellular parasite of mononuclear cells in vivo and in vitro
(19) and evades phagosome-lysosome fusion within these
cells (16). The phagosomes harboring L. pneumophila are studded by ribosomes during certain periods
(37). Several L. pneumophila virulence factors
facilitating intracellular growth have been identified in screens using
macrophages or macrophage-like cell lines (24, 25). One
important set of virulence factors is the dot/icm system,
which is required for evasion of phagosome-lysosome fusion (3,
34, 35) and establishment of the phagosomes permissive for
growth of L. pneumophila within them (6).
In a previous study, we described a broad range of potential L. pneumophila virulence genes in a guinea pig pneumonia model by
using a signature-tagged mutagenesis method (12). In that study, three different classes of macrophage virulence phenotypes were
discovered. One group of mutants had a markedly reduced ability to
multiply within macrophages and included mutants of the already known
dot/icm complex (3, 35). Another group of
mutants was able to multiply efficiently within macrophages. A third
group of mutants had an initial defect in intracellular multiplication but were able to multiply in macrophages as well as the wild-type strain after prolonged incubation. Partial sequencing of the
transposon-interrupted genes of two prototrophic mutants of this third
group showed homology to the Escherichia coli
phosphoenolpyruvate phosphotransferase (ptsP)
(33).
The E. coli ptsP ortholog facilitates nitrogen utilization
via a complex two-component sensing and regulatory phosphate transfer system. The E. coli ptsP gene encodes enzyme
INtr (EINtr), consisting of two domains: an
N-terminal domain of 127 amino acids homologous to the N-terminal
sensory domain of the NifA protein of Azoto bacter
vinelandii, and a C-terminal domain of 578 amino acids homologous
to all other currently sequenced EI proteins (33).
Sequence analysis suggests that EINtr serves a sensory
function linking carbon and nitrogen metabolism (33). The
C-terminal domain of EINtr transfers a phosphate from
phosphoenolpyruvate to a histidine residue of the phosphocarrier
protein NPr (32). NPr in turn transfers a phosphate to the
cell membrane EIIANtr, which has a role in the regulation
of
54 -dependent transcriptional initiation of genes
concerned with organic nitrogen utilization (31). NPr and
EIIANtr are encoded in the rpoN operon,
suggesting that ptsP is involved in the transcriptional
regulation of rpoN-dependent operons (31).
In this study, the L. pneumophila ptsP ortholog gene was
completely sequenced and its deduced amino acid sequence was analyzed. The ptsP mutant was characterized phenotypically, and
complementation studies were performed to confirm that the interrupted
gene itself was required for in vivo and in vitro virulence.
 |
MATERIALS AND METHODS |
Bacteria and plasmids.
L. pneumophila
serogroup1 strain AA100jm (12) is a spontaneous
streptomycin-resistant mutant of strain 130b (28) which is
virulent in guinea pigs, macrophages, and amoebae (12,
29). Clones 47:3h and 47:4a are ptsP mutants, and
clone 47:2f is a dotO mutant of AA100jm. dotO is
within the icm/dot gene cluster and involved in
intracellular growth and evasion of the endocytic pathway
(1). They were made by transposon mutagenesis of AA100jm using Tn903HT (Tn903 harboring a signature tag)
(12). L. pneumophila strains were grown at
35°C in a humidified incubator either on MOPS
[3-(N-morpholino)propanesulfonic acid]-buffered charcoal yeast extract agar medium supplemented with
-ketoglutarate
(BCYE-
) (11) or in ACES
[N-(2-acetamido)-2-aminoethanesulfonic acid]-buffered yeast extract broth supplemented with
-ketoglutarate (BYE-
) (11). E. coli K-12 and K29 were serum sensitive
and serum resistant, respectively (17), and were gifts
from Marcus Horwitz. E. coli strain XL-1 Blue (Stratagene)
was grown at 37°C either on Luria-Bertani agar or in Luria-Bertani
broth. Selective antimicrobial agents were added to the growth media
when appropriate and included kanamycin (30 µg/ml), streptomycin (200 µg/ml), and chloramphenicol (10 [L. pneumophila] or 30 [E. coli] µg/ml). Plasmid pSU2719 (26) was
a gift from Nicolas Cianciotto. Plasmid pSU2719 carries a P15A
replicon, chloramphenicol acetyltransferase, and LacZ
and can
multiply within L. pneumophila. Plasmid pUC18 was purchased from Life Technologies, Gaithersburg, Md.
Nucleic acid manipulation.
All nucleic acid manipulations
were accomplished according to standard molecular biology techniques
(2).
Complete sequencing of the ptsP gene.
Genomic
DNA from mutant clone 47:3h (AA100jm
ptsP838::Tn903HT) or mutant clone 47:4a
(AA100jm ptsP1240::Tn903HT)
was digested with restriction enzymes known not to cut the transposon
insertion upstream of the kanamycin resistance gene (Kmr)
cassette. Digested DNA was ligated into pUC18, which was appropriately digested. E. coli strain XL-1 Blue was transformed with the
ligated product by electroporation. Plasmid DNA of Kmr
transformants was restriction digestion mapped to confirm proper insertion of the desired DNA fragment into the plasmid. Plasmid DNA was
purified by using a Quiagen spin filter (Quiagen), and the insert DNA
was sequenced by a primer walking technique. An ABI Big Dye Taq FS
terminator sequencing kit (Applied Biosystems) was used to synthesize
the dye-terminated DNA, which then was sequenced by using an ABI 377 automated sequencer (University of Pennsylvania Sequencing Facility).
Whole sequence data were analyzed and aligned using SeqMan II software,
version 4.03 (DNASTAR Inc., Madison, Wis.). GenBank sequence database
searching was performed with the BLASTX and BLASTN search algorithms.
Deduced amino acid sequences were analyzed with Motif
(http://www.motif.genome.ad.jp) and SOSUI
(http://azusa.proteome.bio.tuat.ac.jp/sosui/). Multiple sequence alignments were performed using Megalign, version 4.03, with
the Jotun Hein method (DNASTAR).
Macrophages and alveolar epithelial cells.
Guinea pig
alveolar macrophages were prepared as previously described
(12) and cultured in medium 199 (M199; Life Technologies) supplemented with 10% fetal bovine serum (Bio Whittaker, Walkersville, Md.). A549, a human alveolar epithelial cell line received as a gift
from Michael Beers, was maintained in M199-10% fetal bovine serum.
A549 cells were harvested at logarithmic growth phase, using 10 mM
EDTA-phosphate-buffered saline (PBS) solution and 5% trypsin-PBS. The
alveolar epithelial cells (1.25 × 105/well) were
cultured overnight in 24-well culture tray in 5% CO2 air
at 37°C and then used for experiments. Murine bone marrow-derived macrophages were prepared from A/J mice as reported previously (34).
Serum killing assay.
Normal serum was collected from healthy
guinea pigs. The antibody titer of the serum against L. pneumophila SG1 was 1:32, as measured by indirect
immunofluorescence, as described previously, but modified to detect
guinea pig antibodies by use of fluorescein-labeled goat anti-guinea
pig immunoglobulin G antibody (ICN Biomedicals, Aurora, Ohio)
(8). Immune guinea pig serum was obtained from animals
infected with sublethal doses of L. pneumophila and had an
indirect immunofluorescence assay titer of 1:256. Serum was heat
inactivated at 56°C for 30 min when needed. Bacteria (108
CFU/ml) were incubated in phosphate buffer supplemented with Ca2+ and Mg2+ (pH 7.35) with or without serum
at 37°C for 1 h. The suspensions were then diluted in decimal
dilutions with Mueller-Hinton broth (MHB) and plated onto BCYE-
agar
plates, which were incubated for 3 days. Surviving bacteria were
enumerated by counting CFU on the plates.
Neutrophil killing assay.
Human peripheral polymorphonuclear
leukocytes were purified by density gradient centrifugation and dextran
sedimentation as described previously (4). The killing
assay was performed using 20% human serum, as previously described
(18), with one exception. M199 was used to suspend the
bacteria and neutrophils rather than Hanks' balanced salt solution, as
the Legionella bacteria were killed by the salt solution.
Determination of flagellation.
Plate-grown
Legionella bacteria were suspended in sterile distilled
water and stained for the presence of flagellae, using the Ryu stain
(Remel Laboratories, Lenexa, Kans.), as described previously (9,
22).
Invasion assay.
Guinea pig alveolar macrophages were
infected with bacterial (multiplicity of infection [MOI] at 50) in
24-well microplates, after which the plates were centrifuged at
100 × g for 8 min at room temperature. The infected
macrophages were then incubated at 37°C in 5% CO2 air
for 2 h. The infected macrophages were washed with warm M199 three
times and incubated with or without gentamicin (50 µg/ml) for 1 h. The macrophages were then washed with warm M199 three times. The
infected macrophages were harvested at indicated points in sterile
distilled water and then lysed by vortex mixing for 1 min. The lysate
was plated quantitatively on BCYE-
medium. A separate experiment
showed that there were no significant increases in intracellular
bacterial concentrations during the 1-h gentamicin incubation period
(data not shown).
Intracellular growth assay.
Macrophages or alveolar
epithelial cells were prepared as described above, infected with
L. pneumophila (MOI of 0.1), and then incubated in 5%
CO2 air at 37°C. Culture supernatants were harvested at
indicated times, diluted appropriately with MHB, and then plated onto
BCYE-
agar plates. In some experiments the cultured cells were lysed
in the tissue culture wells either by low-energy sonication or by
hypotonic lysis with distilled water; neither method affects the
viability of L. pneumophila.
Pore formation assay.
L. pneumophila
contact-induced pore formation in the macrophage membrane was assayed
as described previously (40). In these assays, L. pneumophila was added at the given MOIs to 1.5 × 105 mouse bone marrow-derived macrophages plated on
coverslips in 24-well microplates. Rabbit anti-L.
pneumophila polyclonal antibody was added to each well. The tissue
culture plates were centrifuged at 150 × g for 5 min
at room temperature and incubated for 1 h at 37°C. The
coverslips were then stained with ethidium bromide (25 µg/ml) and
acridine orange (5 µg/ml). All cells will stain with acridine orange,
whereas an intact macrophage membrane will exclude ethidium bromide.
Pore-forming activity was measured as the percentage of macrophages
that stain positive with ethidium bromide. Coverslips were examined
with a Zeiss Axioplan II microscope. A rhodamine bandpass filter set
was used to detect ethidium bromide, and a fluorescein isothiocyanate
bandpass filter set was used to detect acridine orange staining.
Phagosome trafficking assay.
Trafficking of phagosomes
harboring L. pneumophila within murine bone marrow-derived
macrophages was assayed as described previously (34).
Briefly, the macrophages (8 × 104) on glass
coverslips in a 24-well microplate were infected with L. pneumophila at an MOI of 50. The plates were centrifuged at 150 × g for 5 min at room temperature to optimize
bacterial uptake. Infected macrophages were incubated for 30 min at
37°C in 5% CO2 air; then the cells were washed and fixed
in paraformaldehyde. The coverslips were immersed in ice-cold methanol
for 10 s to permeabilize the cells and then blocked in PBS
containing 2% goat serum for 1 h. Lysosomes were stained with
anti-murine Lamp-1 rat antibody (1D4B; 1:250), followed by fluorescein
isothiocyanate-labeled anti-rat immunoglobulin secondary antibody
(1:250). Bacteria were stained with 4',6-diamidino-2-phenylindole. All
antibody washes were in PBS. Coverslips were inverted onto 2 µl of
mounting media before viewing. Bacterial phagosomes were scored for
Lamp-1 staining by standard epifluorescence microscopy.
Electron microscopic observation.
Guinea pig alveolar
macrophages were cultured on sterile plastic coverslips and then
infected with L. pneumophila (MOI of 0.1). The infected
cells were incubated for 2 or 3 days. Then the infected macrophages
were fixed with 2% glutaraldehyde in PBS and washed with ice-cold PBS.
Fixed materials were processed using standard technique and examined in
an electron microscope (Biomedical Image Core Facility, University of Pennsylvania).
Trans-complementation of L. pneumophila ptsP
mutation.
A DNA fragment containing the L. pneumophila
ptsP gene was amplified by the PCR from L. pneumophila
AA100jm genomic DNA, using the upstream sense primer (mu-3h10;
5'-AATACTGCAGTGGGTGGATTTTCAT-3') and the
downstream antisense primer (mu-3h11;
5'-TTAGGATCCCGCCATTATTCCTG-3'). BamHI
and PstI sites respectively (underlined), were incorporated into these primers. Amplification was performed using Vent polymerase (New England Biolabs, Beverly, Mass.). The amplified products of the
ptsP gene were digested with BamHI and
PstI and then ligated with pSU2719, which had been digested
with appropriate enzymes and dephosphorylated. E. coli XL-1
Blue was transformed with the ligated product by electroporation.
Plasmid DNA of chloramphenicol-resistant (Cmr)
transformants was restriction digested-mapped to confirm proper insertion of the desired DNA fragment into the plasmid. The cloned ptsP gene was sequenced as stated above to verify no
erroneous incorporation of nucleotides during amplification. A single
clone containing the whole ptsP gene was picked for further
study, and the plasmid was designated pHT28a. Plasmid DNA was purified
by using a Quiagen spin filter. The ptsP mutant of AA100jm,
clone 3h, was transformed with pHT28a by electroporation. Plasmid DNAs from several Cmr transformants were restriction digestion
mapped to confirm the presence of the desired plasmid. One of the
transformants containing the desired plasmid was picked for further
studies and designated HT31a. PCR testing of HT31a using
ptsP-specific primers showed that it contained the
full-length ptsP gene, in contrast to the noncomplemented
mutant. Empty pSU2719 was electroporated into the mutant (clone 47:3h)
as well the parent (AA100jm) to serve as negative controls; these were
designated HT32a and HT34a, respectively.
Animal model.
The guinea pig model of L. pneumophila pneumonia was used as described previously
(10). L. pneumophila was grown in BYE-
broth
under the appropriate selective conditions and was diluted in sterile
water at a concentration of 3.3 × 106 CFU/ml;
106 CFU was injected into the surgically exposed tracheas
of Hartley strain male guinea pigs weighing ~250 g. The animals were
killed 2 days later. The right lower lung lobe and spleen were removed aseptically, weighed and ground in MHB, and then diluted in the same
broth type in decimal dilutions. Diluted tissue homogenates were plated
onto BCYE-
with or without kanamycin. Another experiment extended
the postinfection observation time to 7 days.
Immunoblot analysis.
To identify expression of DotA protein
and IcmX protein in the ptsP mutant and its parent, Western
blotting was used (27, 34). Plate-grown colonies of
bacteria were sonicated (for DotA) or boiled (for IcmX), then lysed in
Laemmli sample buffer, and applied to a sodium dodecyl
sulfate-polyacrylamide gel. Separated proteins were transferred
electrophoretically to Immobilon-P membranes (Millipore). The membranes
were probed with a polyclonal rabbit antibody against DotA (gift from
Craig R. Roy; 1:1,000) or a polyclonal rabbit antibody against IcmX
(gift from Craig R. Roy; 1:500) and alkaline-phosphatase conjugated
anti-rabbit secondary antibody (Boehringer Mannheim). The proteins were
visualized using nitroblue tetrazolium and
5-bromo-4-chloro-3-indolylphosphate. All blocking and antibody
dilutions were performed in 1 × PBS containing 5% nonfat dry milk and
0.1% Tween 20.
Nucleotide sequence accession number.
The ptsP
sequence has been deposited in the GenBank database at the National
Center for Biotechnology Information under accession number AF181870.
 |
RESULTS |
Complete sequence of the ptsP gene.
Sequencing of
the region surrounding the transposon insertion sites of mutant clones
47:3h and 47:4a was completed and verified for a region 3,624 bp in
length. The largest open reading frame (ORF1) consisted of 2,295 bp.
The two transposon insertion sites were within this ORF, 827 and 1241 bp downstream of the start site, for clones 47:3h and 47:4a,
respectively (Fig. 1). No significant homology was discovered with sequences deposited in the nonredundant GenBank database, using the BLASTN search algorithm. However, use of
the BLASTX search algorithm revealed that ORF1 had high homology with
the EINtrptsP gene of Pseudomonas
aeruginosa (score, 825; identities, 413/759 [54%]; positives,
551/759 [72%]; expected, 0.0), the phosphotransferase EI of A. vinelandii (822; 413/759 [54%]; 558/759 [73%]; 0.0), and the
ptsP EINtr of E. coli (610; 337/767
[43%]; 471/767 [56%]; e
173). ORF1 was designated
L. pneumophila ptsP. All four of these homologous proteins
shared many conserved regions, especially the region around the
histidine residue that is the putative phosphorylation site. Also
highly conserved was the region that represents the motif of the
phosphoenolpyruvate-utilizing enzyme signature 2 (Prosite PS00472;
positions 628 to 646 in amino acid sequence of L. pneumophila
ptsP). Both the N-terminal and C-terminal domains of the E. coli EINtr were highly conserved in the L. pneumophila ptsP. SOSUI analysis (15) predicted that
L. pneumophila ptsP is a soluble protein and located in the
inner membrane.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 1.
Scheme of the ptsP operon. Each arrow
represents an ORF. The transposon insertion sites of mutants 47:3h and
47:4a are shown as arrowheads. The gene region used for complementation
is shown as a halftone box. The nucleotide numbering refers to that of
L. pneumophila ptsP as published in GenBank
(AF181870).
|
|
A second ORF, designated ORF2, was immediately upstream of the
ptsP ortholog and in the same reading frame. This 528-bp ORF shared significant homology with the P. aeruginosa invasion
protein homolog gene (invA; score, 184; identity, 83/147
[56%]; positives, 111/147 [75%] expected, 4e
46;
AF116285). These ptsP and invA orthologs are in
contiguous regions and in the same orientation in both bacteria
(39). ORF2 was also homologous to MutT-like proteins in a
variety of other bacteria and to invA of Rickettsia
prowazekii and other bacteria. No putative promoter regions were
identified immediately upstream of the ptsP ortholog, but a
possible promoter was found starting 39 bp upstream of ORF2
(http://www.fruitfly.org/seq_tools/promoter.html).
Growth of the ptsP mutants and complemented mutants in
guinea pigs.
Intrapulmonary growth of two different
ptsP mutants was assessed using a guinea pig pneumonia
model. Two days after intratracheal inoculation of guinea pigs, the
parent strain multiplied by at least 100-fold in the lungs, whereas
neither of the mutants multiplied in the lungs (Fig.
2). Parent, but not mutant, strain
bacteria were recovered in high concentrations from the spleens. Three of four animals inoculated with the mutant bacteria had no detectable bacteria recovered from their spleens, and the fourth animal's spleen
contained bacteria in a concentration just above the detection limit of
100 CFU/spleen. Concentrations of the mutant in the lung and spleen
were about 1 and <0.02%, respectively, of the parent concentrations
for the same organs in different animals.

View larger version (72K):
[in this window]
[in a new window]
|
FIG. 2.
(A) Growth of ptsP mutants generated by
transposon insertion (clones 47:3h and 47:4a) and their parent
(AA100jm) in guinea pigs. Bacteria (106 CFU) were injected
into the surgically exposed tracheas of guinea pigs. The animals were
killed 2 days later, and their lungs and spleens were recovered
aseptically. Bacterial burdens in the lungs and the spleens of infected
animals were determined as stated in the text. (B) Recovery of L. pneumophila from guinea pig lung and spleen for the
transcomplemented ptsP mutant HT31a (ptsP mutant
carrying pHT28a), for the mutant with empty plasmid HT32a
(ptsP mutant carrying pSU2719), or for the parent with empty
plasmid, HT34a (parent carrying pSU2719). Plasmid pSU2719 is the
plasmid vector; pHT27a consists of pSU2719 and the ptsP ORF.
These strains were inoculated into guinea pig tracheas, and bacterial
burdens in the lungs and spleens were determined 2 days later.
|
|
The transcomplemented mutant, HT31a, had partial restoration of the
parenteral phenotype (HT34a) in the guinea pig pneumonia model and was
recovered from both lung and spleen in 10- and 100-fold-higher concentrations, respectively, than the mutant with empty vector, HT32a
(Fig. 2). Animals infected with HT31a experienced significant weight
loss and fever, in contrast to animals infected with HT32a, which had
neither significant weight loss nor fever (Fig.
3). There was considerable in vivo
plasmid loss from all three strains; about 27.5, 1.9 and 5.8% of
bacteria recovered from the lungs of animals challenged with HT31a,
HT32a, and HT34a, respectively, were Cmr, whereas 100% of
the starting inocula for all three strains were Cmr. All
eight randomly chosen Cmr colonies of HT31a isolated from
guinea pig lungs contained the expected plasmid and complete
ptsP gene, by plasmid restriction mapping and PCR testing,
respectively. This confirmed that the HT31a animal group had indeed
received HT31a. The overall results showed that a large portion of
virulence defect of the ptsP mutants could be attributed to
a mutation in ptsP, although additional downstream virulence
genes could not be completely excluded.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 3.
Signs of L. pneumophila pulmonary infection.
Rectal temperature (A) and body weight (B) of guinea pigs infected with
HT31a (ptsP mutant carrying pHT28a; open triangles), HT32a
(ptsP mutant carrying pSU2719; closed triangles), or HT34a
(parent carrying pSU2719; open circles) were monitored between days 0 and 2 after inoculation of the bacteria. Each point represents the
mean ± SD from three animals.
|
|
To determine if the ptsP mutant would cause delayed disease
in the guinea pig, mirroring the delayed growth of the mutant in guinea
pig alveolar macrophages, four guinea pigs each were infected with
either the parent (1.4 × 106 CFU/animal) or
ptsP mutant (1.9 × 106 CFU/animal) and
observed for 7 days postinfection. All four guinea pigs infected with
the parent strain appeared clinically ill, developed fever (
+ 1.5°C change from baseline), and exhibited weight loss (mean,
21%
from baseline); three of four animals died of pneumonia by day 5 postinfection, and one survived to day 7. In contrast, all four animals
infected with the mutant bacterium appeared clinically well, survived
to 7 days postinfection, and gained weight (mean, +18% from baseline).
The only evidence of disease in the animals infected with the mutant
bacterium was a slight (mean, +0.4°C), though statistically
significant (P = 0.01, paired t test),
increase in body temperature on postinfection day 2 only. Of note, this
slight fever peak occurred 1 day later than did the maximum fever
observed for the parent-infected animals. Postmortem findings in the
two animal groups showed that the animals infected with the
ptsP mutant had significantly lower lung weights (mean, 6.2 versus 3.0 g), bacterial lung counts (mean, 2.4 × 109
versus 6.7 × 103 CFU/lung), and bacterial spleen
counts (9.6 × 103 versus 4.5 × 101
CFU/spleen) than did animals infected with the parent strain (P < 0.03 for all comparisons). These findings show
that ptsP is required for full virulence of L. pneumophila in guinea pigs and that delayed animal virulence is
not observed for infection with a ptsP mutant.
Intracellular growth and uptake characteristics.
To determine
if the reduced guinea pig virulence of the ptsP mutant was
due to an intracellular growth defect, we examined its growth within
explanted guinea pig alveolar macrophages and a human alveolar
epithelial cell line. The parent strain grew well within both cell
types, contrast to the deficient growth of the mutant (Fig.
4). In alveolar macrophages, the
ptsP mutant supernatant concentration decreased on day 1 in
comparison to its starting concentration and that of the parent strain,
but there after the mutant grew as fast as the parent (Fig. 4A).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 4.
Growth of L. pneumophila within guinea pig
alveolar macrophages and human alveolar epithelial cells. (A) Guinea
pig alveolar macrophage Triangles, ptsP mutant (clone
47:3h); circles, parent (AA100jm). (B) A549, human alveolar epithelial
cell line. Symbols have the same meaning as in panel A. CFU in each
well was determined at indicated times. Each time point represents
mean ± SD of triplicate wells. Bacterial growth is expressed as
the log10 of the ratio of the bacterial concentration at
the indicated time to the bacterial concentration at the start of the
experiment.
|
|
To exclude the possibility that growth of the mutant was normal in
alveolar macrophages but blocked from cellular release, several
additional studies were performed with alveolar macrophages. First,
microscopic examination of ptsP mutant-infected alveolar macrophages showed that the infected macrophages appeared
morphologically identical to those observed for the parent
strain-infected macrophages. Specifically, there was not an abundance
of nonlysed heavily infected macrophages for the ptsP
mutant-infected macrophages. Second, a study that examined the parent
and mutant bacterial concentrations from cell culture lysates and
supernatants showed that the ptsP mutant had the same growth
defect versus the parent strain, for both the tissue culture lysates
and supernatants (data not shown).
In contrast to findings in alveolar macrophages, the ptsP
mutant apparently did not multiply at all within the A549 human alveolar epithelial cell line, whereas the parent strain grew well
(Fig. 4B). Subsequent experiments that examined A549 cell lysates
showed that there was very slow intracellular growth of the
ptsP mutant in A549 cells, which was masked by the higher extracellular bacterial concentration in the supernatant alone. By day
4 of the experiment, the concentration of the ptsP mutant in
the lysate was equivalent to that of the extracellular concentration (data not shown). This was in contrast to the roughly equivalent concentrations of the parent strain in the supernatant and cell lysate
from day 1 on.
Because the initial slow growth of the ptsP mutant in the
guinea pig alveolar macrophages could be due to reduced uptake of the
mutant by the macrophages, invasion of macrophages by the bacterium was
assessed using a gentamicin protection assay. This showed that the
fractions of internalized bacteria were about the same for the both the
parent and mutant strains. The total number of bacteria for macrophages
infected with the parent strain was (48 ± 14 [standard deviation
{SD}]) × 104 CFU and the number of intracellular
bacteria remaining after gentamicin incubation was (6.2 ± 1.2) × 104 CFU, or an intracellular-to-total bacteria
ratio of 13%. For the 47:3h ptsP mutant, the respective
numbers were (32 ± 9) × 104 CFU, (6.8 ± 2) × 104 CFU, and 21%.
Effect of ptsP transcomplementation on
intracellular growth.
To determine if transcomplementation
of the ptsP mutant restored its ability to grow within
cells, it was used to infect guinea pig alveolar macrophages and
A549 cells. The transcomplemented mutant (HT31a) grew within
macrophages almost as well as its parent containing empty vector, HT34a
(Fig. 5A). Complementation of
ptsP also restored growth of the mutant within A549 cells to
levels intermediate between the mutant containing empty vector and the parent with empty vector (Fig. 5B).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 5.
Complementation of ptsP in trans
rescues the intracellular growth of L. pneumophila within
guinea pig alveolar macrophages and human alveolar epithelial cells.
(A) Guinea pig alveolar macrophage. (B) A549, human alveolar epithelial
cell line. Cells were infected with HT31a (transcomplemented
ptsP mutant harboring pHT28a; open triangles), HT32a
(ptsP mutant harboring empty pSU2719; closed triangles), or
HT34a (parent harboring empty pSU2719; open circles) at an MOI of 0.1. pSU2719 is the plasmid vector used; pHT28a consists of pSU2719 and
ptsP ORF. Each time point in panel A represents mean ± SD of six (at days 0 and 1) or seven (at days 2 and 3) wells. Each time
point in (panel B) represents mean ± SD of quadruplicate wells.
Bacterial growth is expressed as the log10 of the ratio of
the bacterial concentration at the indicated time to the bacterial
concentration at the start of the experiment.
|
|
Extracellular phenotypic characterization of the mutant.
Extracellular growth of the ptsP mutant (clone 47:3h) in
BYE-
broth was the same as was observed for the parent type strain (AA100jm) (data not shown). We previously showed that both clones 47:3h
and 47:4a are prototrophic (34). Microscopically, the parent strain appeared as short thin rods, while the ptsP
mutant was longer, but as thin as its parent, at log-growth phase. At stationary phase (optical density at 660 nm of >1.0), more filamentous forms were seen with the ptsP mutant than wild type. The
mutant showed the same Sudan black B-positive deposits as the parent strain, both at log phase and at stationary phase. Both the parent and
mutant produced monopolar and dipolar flagella. Colonial morphology of
the mutants and the parent was indistinguishable.
Both the mutant and its parent were resistant to serum
complement-mediated killing. No reductions in bacterial concentrations were observed in the presence of 20% fresh serum, whereas the same
concentration of serum combined with immune serum resulted in 4.4 and
4.7 log10 killing, respectively, of both parent and mutant.
In contrast, a serum-sensitive strain of E. coli was killed by 4.8 log10 in the presence of both 10 and 20% fresh
serum. Neither the parent nor the mutant were killed by human
neutrophils; there was less than a 0.5 log10 decrease in
bacterial numbers after incubation with neutrophils for 1 h, which was
indistinguishable from the decrease in bacterial counts observed in the
presence of tissue culture medium and serum, in the absence of
neutrophils. This was in contrast to a 2 log10 decrease of
the control E. coli strain in the presence, but not absence,
of neutrophils.
Pore formation, intracellular trafficking, and phagosome
ultrastructural morphology.
To determine if the initial slow
growth of the ptsP mutant was related to decreased pore
formation of macrophages, bacterium-induced pore formation in murine
bone marrow-derived macrophages was compared to that of the parent
strain, as well as to that of a dotO mutant, using cell
permeability to ethidium bromide as a marker of cell pore formation.
DotO mutants are unable to form pores in macrophages (1).
Both the parent and ptsP mutant formed pores in the majority of macrophages studied, while macrophages infected with the
dotO mutant did not form pores. At an MOI of 1,000, the
ptsP mutant formed pores in 60.0% ± 10.8% of cells,
versus 79.3% ± 3.0% and 1.6% ± 1.0% for cells infected by the
parent and dotO mutants, respectively. At an MOI of 10, the
frequencies of cell pore formation were 52.9% ± 7.5%, 60.7% ± 25.3%, and 2.0% ± 1.1% for the ptsP mutant, parent, and
dotO mutant, respectively. These results show that the
ptsP mutation had no effect on cytotoxicity.
L. pneumophila normally blocks maturation of its phagosome
(16), and a defect in this ability could affect
intracellular growth. The ability of the ptsP mutant to
inhibit the colocalization of the lysosomal membrane marker Lamp-1
within the phagosome was assessed by microscopy using murine bone
marrow-derived macrophages. Thirty minutes after infection, only 8.7%
(10/114) of phagosomes harboring the ptsP mutant (clone
47:3h) and 5.5% (6/109) of the parent strain were colocalized with
Lamp-1, in contrast to the 73.8% (93/126) colocalization frequency for
phagosomes containing the dotO mutant. This result indicated
that the ptsP mutation did not impair the ability of the
bacterium to inhibit phagosome maturation.
The ultrastructure of phagosomes containing the ptsP mutant
or its parent was examined using guinea pig alveolar macrophages to
determine if mutant-containing phagosomes were ribosome studded, as is
observed for wild-type L. pneumophila. Two days after
infection of macrophages with the parent strain (MOI = 0.1), 14 (38.9%) of 36 infected macrophages contained ribosome-studded
phagosomes (Fig. 6A). Too few macrophages
to score by electron microscopy were infected with the ptsP
mutant at the same MOI 2 days after inoculation. Three days after
infection of macrophages with the mutant, most macrophages were
infected; among 40 macrophages infected, 15 contained ribosome-studded
phagosomes (37.5%) (Fig. 6B). The phagosomes containing the
ptsP mutant appeared to be slightly more spacious than the
phagosomes containing the parent strain, but quantitative morphometric
studies were not performed.

View larger version (106K):
[in this window]
[in a new window]
|
FIG. 6.
Electron microscopy of phagosomes containing a
ptsP mutant or its parent. Guinea pig alveolar macrophages
were infected with bacteria as described in the text. (A) Parent
(AA100jm) at day 2 after infection. (B) ptsP mutant (clone
47:3h) at day 3 after infection. Magnification, ×40,000. A 500-nm size
marker is shown.
|
|
DotA and IcmX production.
To determine if the ptsP
mutation had an effect on the dot/icm system, we examined
DotA protein and Icm X protein expression of the mutant. Crude lysates
of both the parent and ptsP mutant applied in equivalent
protein amounts to the polyacrylamide gel showed apparently identical
amounts of DotA by immunoblot assay. Similarly, boiled samples of both
the parent and ptsP mutant and F2345 applied in equivalent
protein amounts to the polyacrylamide gel showed apparently identical
amounts of IcmX protein (data not shown). These data indicate that the
ptsP mutation does not affect dotA and
icmX regulation.
 |
DISCUSSION |
We have demonstrated that the L. pneumophila ptsP gene
is an important virulence factor for cell and guinea pig infection. Mutations at two different sites in the gene dramatically reduced the
ability of the bacterium to multiply in guinea pig lungs and also
eliminated the extrapulmonary invasiveness of the bacterium. This
reduced virulence is attributable to the reduced ability of the mutant
bacterium to multiply within macrophages without affecting its ability
to invade cells. The architecture of the L. pneumophila ptsP
gene is very similar to that found in P. aeruginosa in that
both the ptsP and invA orthologs are in
contiguous regions, and in the same orientation (39).
There is also considerable homology between the L. pneumophila, P. aeruginosa (39), and A. vinelandii (36) orthologs of the ptsP gene
itself, indicating a common genetic origin.
Proof that the ptsP mutation itself is responsible for the
reduced-virulence phenotype was provided by the complementation studies. Transcomplementation of ptsP increased the
virulence of the noncomplemented mutant about 50-fold in cultured cells and 10-fold and 250-fold in guinea pig lung and spleen, respectively, and fully restored the clinical virulence of the bacterium. In comparison with the parent strain, transcomplementation of
ptsP almost completely restored the ability of the mutant to
grow within alveolar epithelial cells and reversed its initial growth
defect within alveolar macrophages. Also, ptsP
transcomplementation almost completely restored the ability of the
mutant to multiply in the lung and invade the spleen of guinea pigs. We
attribute partial, rather than full, restoration of the mutant to the
parenteral phenotype to plasmid loss in the absence of antibiotic
selection in the animal and cellular infection models. There is no
practical way to maintain chloramphenicol selection in vivo or in cell
culture, as chloramphenicol appears to be ineffective against normally Cms L. pneumophila in both systems
(7). Nonantimicrobial selective pressure favored the
growth of the complemented mutant, in that it was more able to multiply
in tissues when it contained the plasmid than when it lacked it; this
is demonstrated by the greater than 10-fold difference in plasmid
retention between the complemented mutant and the mutant with the empty plasmid.
An equally valid alternative explanation for the incomplete
restoration of the parenteral virulence phenotype by
transcomplementation is that there was a polar effect on downstream
virulence genes in the same operon. Examination of the published
sequence of a related L. pneumophila serogroup 1 strain
shows that there are two large ORFs downstream of ptsP
in what may be the same operon (http://genome3.cpmc.columbia.edu/%7Elegion/).
Since the ptsP trancomplementation by itself had a dramatic
effect on the virulence phenotype, these putative downstream virulence
genes would have to act in concert with ptsP to cause full
virulence. Several attempts at making an unmarked nonpolar mutation of
ptsP were unsuccessful in our hands, precluding definitive
resolution of this point.
Our studies indicate that the ptsP mutant invades
macrophages normally and hence that its intracellular multiplication is slowed due to poor growth once the bacterium is intracellular. This
poor growth could be due either to growth of only a small fraction of
invading bacteria or to a longer than normal lag phase of growth of all
the invading bacteria. In alveolar macrophages the bacteria eventually
multiply to levels observed for the parent strain, indicating that the
intracellular growth rate normalizes after a long lag. Normalization of
the growth rate is consistent with the results of the ultrastructural
and endosome maturation studies, which showed that the mutant resides
in a parenteral-type phagosome with inhibition of endosomal maturation.
The significance of the slightly more spacious nature of the phagosomes
containing the mutant is unknown. Taken together, these findings
suggest that the intracellular multiplication defect is an early event, eventually bypassed by unknown factors. The delayed normalization of
growth within macrophages did not have an in vivo correlate, probably
because guinea pig host defenses develop quickly, enabling the host
defenses to overcome an initially slowly growing bacterium.
Growth of L. pneumophila within alveolar epithelial cells
has been suggested to be a virulence determinant, in that bacterial mutants capable of growing within alveolar epithelial cells, but not
alveolar macrophages, retained their virulence in a mouse pneumonia
model (14). Defective growth of the ptsP mutant
in alveolar epithelial cells may partially or wholly explain why the
guinea pig virulence of the mutant is so attenuated, despite the
ability of the bacterium to eventually multiply normally in alveolar
macrophages and to possess the parenteral phagosomal phenotype.
Alteration in the regulation of the dot/icm system is not an
explanation for the reduced virulence of the ptsP mutant. Unlike dot/icm mutants, the ptsP mutant
established ribosome-studded phagosomes, normally inhibited endosomal
maturation, and formed host cell membrane pores. In addition, DotA and
IcmX appear to be normally produced by the ptsP mutant.
The function and the pathogenic and nonpathogenic roles of the
L. pneumophila ptsP gene are unknown. The deduced amino acid sequences of known ptsP homologs and L. pneumophila
ptsP were well conserved. Among them, E. coli ptsP has
been investigated most intensively. The E. coli ptsP gene
encodes EINtr, which is thought to serve a sensory function
linking carbon and nitrogen metabolism (33). In addition,
EINtr may play a role in the transcriptional regulation of
rpoN-dependent operons (31). A variety of
bacterial virulence traits are linked to rpoN-dependent
operons, including Pseudomonas syringae virulence for tomato
plants (23), Vibrio anguillarum fish virulence
(30), Agrobacterium tumefaciens plant virulence
(5), and V. cholerae virulence for mice
(21). We speculate that the L. pneumophila ptsP
ortholog is involved in signal transduction for expression of a
virulence factor, which may be through regulation of the rpoN operon.
There are few studies on the phenotypic effects of ptsP
mutations of other bacteria. Mutation of the P. aeruginosa
ptsP ortholog results in reduced virulence for
Caenorhabditis elegans and mice, by an unknown mechanism
(38, 39). Mutational inactivation of the A. vinelandii ptsP ortholog affects poly-
-hydroxybutyrate accumulation (36). L. pneumophila is known to
deposit
-hydroxybutyrate within its cytoplasm as a nutrition source
for long-term starvation survival (20). Our results show
that the L. pneumophila ptsP gene is apparently not
responsible for
-hydroxybutyrate accumulation, as the broth-grown
ptsP mutant showed the same amount of Sudan black B-positive
deposits as its parent.
In summary, this study demonstrates that the ptsP ortholog
is required for full expression of virulence of L. pneumophila in vivo. The ptsP mutation results in an
initial defect of growth within macrophages and inability to grow
within alveolar epithelial cells. The sequence homology search suggests
that the gene may be involved in signal transduction of virulence,
which requires further study to elucidate the mechanism. Such studies
will give us new insights into the molecular pathogenesis of L. pneumophila.
 |
ACKNOWLEDGMENTS |
We thank Martha Edelstein for excellent technical assistance;
Craig Roy for helpful discussion, provision of reagents, and instruction in the intracellular trafficking experiments; and Lalita
Ramakrishnan for critical review of the manuscript.
Futoshi Higa was supported by a study grant from Japanese Ministry of
Education, Sports, and Culture.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Clinical
Microbiology Laboratory, 4 Gates, Department of Pathology and
Laboratory Medicine, Hospital of the University of Pennsylvania, 3400 Spruce St., Philadelphia, PA 19104-4283. Phone: (215) 662-6651. Fax:
(215) 662-6655. E-mail: phe{at}mail.med.upenn.edu.
Editor:
V. J. DiRita
 |
REFERENCES |
| 1.
|
Andrews, H. L.,
J. P. Vogel, and R. R. Isberg.
1998.
Identification of linked Legionella pneumophila genes essential for intracellular growth and evasion of the endocytic pathway.
Infect Immun.
66:950-958[Abstract/Free Full Text].
|
| 2.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl (ed.).
1995.
Current protocols in molecular biology.
Wiley, New York, N.Y.
|
| 3.
|
Berger, K. H., and R. R. Isberg.
1993.
Two distinct defects in intracellular growth complemented by a single genetic locus in Legionella pneumophila.
Mol. Microbiol.
7:7-19[Medline].
|
| 4.
|
Boyum, A.
1968.
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.
Scand. J. Clin. Lab. Investig. Suppl.
97:77-89[Medline].
|
| 5.
|
Chesnokova, O.,
J. B. Coutinho,
I. H. Khan,
M. S. Mikhail, and C. I. Kado.
1997.
Characterization of flagella genes of Agrobacterium tumefaciens, and the effect of a bald strain on virulence.
Mol. Microbiol.
23:579-590[CrossRef][Medline].
|
| 6.
|
Coers, J.,
C. Monahan, and C. R. Roy.
1999.
Modulation of phagosome biogenesis by Legionella pneumophila creates an organelle permissive for intracellular growth.
Nat. Cell Biol.
1:451-453[CrossRef][Medline].
|
| 7.
|
Edelstein, P. H.
1995.
Antimicrobial chemotherapy for legionnaires' disease: a review.
Clin. Infect. Dis.
21(Suppl 3):5265-5276.
|
| 8.
|
Edelstein, P. H.
1997.
Detection of antibodies to Legionella spp., p. 502-509.
In
N. R. Rose, E. C. de Macario, J. D. Folds, H. C. Lane, and R. M. Nakamura (ed.), Manual of clinical laboratory immunology, 5th ed. American Society Microbiology, Washington, D.C.
|
| 9.
|
Edelstein, P. H.
1985.
Legionnaires' disease laboratory manual.
National Technical Information Service, Chantilly, Va.
|
| 10.
|
Edelstein, P. H.,
K. Calarco, and V. K. Yasui.
1984.
Antimicrobial therapy of experimentally induced Legionnaires' disease in guinea pigs.
Am. Rev. Respir. Dis.
130:849-856[Medline].
|
| 11.
|
Edelstein, P. H., and M. A. Edelstein.
1993.
Comparison of three buffers used in the formulation of buffered charcoal yeast extract medium.
J. Clin. Microbiol.
31:3329-3330[Abstract/Free Full Text].
|
| 12.
|
Edelstein, P. H.,
M. A. Edelstein,
F. Higa, and S. Falkow.
1999.
Discovery of virulence genes of Legionella pneumophila by using signature tagged mutagenesis in a guinea pig pneumonia model.
Proc. Natl. Acad. Sci. USA
96:8190-8195[Abstract/Free Full Text].
|
| 13.
|
Edelstein, P. H., and R. D. Meyer.
1984.
Legionnaires' disease. A review
Chest
85:114-120[Free Full Text].
|
| 14.
|
Gao, L. Y.,
B. J. Stone,
J. K. Brieland, and Y. Abu Kwaik.
1998.
Different fates of Legionella pneumophila pmi and mil mutants within macrophages and alveolar epithelial cells.
Microb. Pathog.
25:291-306[CrossRef][Medline].
|
| 15.
|
Hirokawa, T.,
S. Boon-Chieng, and S. Mitaku.
1998.
SOSUI: classification and secondary structure prediction system for membrane proteins.
Bioinformatics
14:378-379[Abstract/Free Full Text].
|
| 16.
|
Horwitz, M. A.
1983.
The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes.
J. Exp. Med.
158:2108-2126[Abstract/Free Full Text].
|
| 17.
|
Horwitz, M. A., and S. C. Silverstein.
1980.
Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
J. Clin. Investig.
65:82-94.
|
| 18.
|
Horwitz, M. A., and S. C. Silverstein.
1981.
Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication.
J. Exp. Med.
153:398-406[Abstract/Free Full Text].
|
| 19.
|
Horwitz, M. A., and S. C. Silverstein.
1980.
Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.
J. Clin. Investig.
66:441-450.
|
| 20.
|
James, B. W.,
W. S. Mauchline,
P. J. Dennis,
C. W. Keevil, and R. Wait.
1999.
Poly-3-hydroxybutyrate in Legionella pneumophila, an energy source for survival in low-nutrient environments.
Appl. Environ. Microbiol.
65:822-827[Abstract/Free Full Text].
|
| 21.
|
Klose, K. E., and J. J. Mekalanos.
1998.
Distinct roles of an alternative sigma factor during both free-swimming and colonizing phases of the Vibrio cholerae pathogenic cycle.
Mol. Microbiol.
28:501-520[CrossRef][Medline].
|
| 22.
|
Kodaka, H.,
A. Y. Armfield,
G. L. Lombard, and V. R. Dowell, Jr.
1982.
Practical procedure for demonstrating bacterial flagella.
J. Clin. Microbiol.
16:948-952[Abstract/Free Full Text].
|
| 23.
|
Lorang, J. M., and N. T. Keen.
1995.
Characterization of avrE from Pseudomonas syringae pv. tomato: a hrp-linked avirulence locus consisting of at least two transcriptional units.
Mol. Plant Microbe Interact.
8:49-57[Medline].
|
| 24.
|
Marra, A.,
S. J. Blander,
M. A. Horwitz, and H. A. Shuman.
1992.
Identification of a Legionella pneumophila locus required for intracellular multiplication in human macrophages.
Proc. Natl. Acad. Sci. USA
89:9607-9611[Abstract/Free Full Text].
|
| 25.
|
Marra, A.,
M. A. Horwitz, and H. A. Shuman.
1990.
The HL-60 model for the interaction of human macrophages with the Legionnaires' disease bacterium.
J. Immunol.
144:2738-2744[Abstract].
|
| 26.
|
Martinez, E.,
B. Bartolome, and F. de la Cruz.
1988.
pACYC184-derived cloning vectors containing the multiple cloning site and lacZ alpha reporter gene of pUC8/9 and pUC18/19 plasmids.
Gene
68:159-162[CrossRef][Medline].
|
| 27.
|
Matthews, M., and C. R. Roy.
2000.
Identification and subcellular localization of the Legionella pneumophila IcmX protein: a factor essential for establishment of a replicative organelle in eukaryotic host cells.
Infect. Immun.
68:3971-3982[Abstract/Free Full Text].
|
| 28.
|
Meyer, R. D.,
P. H. Edelstein,
B. D. Kirby,
M. H. Louie,
M. E. Mulligan,
A. A. Morgenstein, and S. M. Finegold.
1980.
Legionnaires' disease: unusual clinical and laboratory features.
Ann. Intern. Med.
93:240-243.
|
| 29.
|
Moffat, J. F.,
P. H. Edelstein,
D. P. Regula, Jr.,
J. D. Cirillo, and L. S. Tompkins.
1994.
Effects of an isogenic Zn-metalloprotease-deficient mutant of Legionella pneumophila in a guinea-pig pneumonia model.
Mol. Microbiol.
12:693-705[CrossRef][Medline].
|
| 30.
|
O'Toole, R.,
D. L. Milton,
P. Horstedt, and H. Wolf-Watz.
1997.
RpoN of the fish pathogen Vibrio (Listonella) anguillarum is essential for flagellum production and virulence by the water-borne but not intraperitoneal route of inoculation.
Microbiology
143:3849-3859[Abstract].
|
| 31.
|
Powell, B. S.,
D. L. Court,
T. Inada,
Y. Nakamura,
V. Michotey,
X. Cui,
A. Reizer,
M. H. Saier, Jr., and J. Reizer.
1995.
Novel proteins of the phosphotransferase system encoded within the rpoN operon of Escherichia coli. Enzyme IIANtr affects growth on organic nitrogen and the conditional lethality of an erats mutant.
J. Biol. Chem.
270:4822-4839[Abstract/Free Full Text].
|
| 32.
|
Rabus, R.,
J. Reizer,
I. Paulsen, and M. H. Saier, Jr.
1999.
Enzyme I(Ntr) from Escherichia coli. A novel enzyme of the phosphoenolpyruvate-dependent phosphotransferase system exhibiting strict specificity for its phosphoryl acceptor. NPr.
J. Biol. Chem.
274:26185-26191[Abstract/Free Full Text].
|
| 33.
|
Reizer, J.,
A. Reizer,
M. J. Merrick,
G. Plunkett, III,
D. J. Rose, and M. H. Saier, Jr.
1996.
Novel phosphotransferase-encoding genes revealed by analysis of the Escherichia coli genome: a chimeric gene encoding an enzyme I homologue that possesses a putative sensory transduction domain.
Gene
181:103-108[CrossRef][Medline].
|
| 34.
|
Roy, C. R.,
K. H. Berger, and R. R. Isberg.
1998.
Legionella pneumophila DotA protein is required for early phagosome trafficking decisions that occur within minutes of bacterial uptake.
Mol. Microbiol.
28:663-674[CrossRef][Medline].
|
| 35.
|
Sadosky, A. B.,
L. A. Wiater, and H. A. Shuman.
1993.
Identification of Legionella pneumophila genes required for growth within and killing of human macrophages.
Infect. Immun.
61:5361-5373[Abstract/Free Full Text].
|
| 36.
|
Segura, D., and G. Espin.
1998.
Mutational inactivation of a gene homologous to Escherichia coli ptsP affects poly- -hydroxybutyrate accumulation and nitrogen fixation in Azotobacter vinelandii.
J. Bacteriol.
180:4790-4798[Abstract/Free Full Text].
|
| 37.
|
Swanson, M. S., and R. R. Isberg.
1995.
Association of Legionella pneumophila with the macrophage endoplasmic reticulum.
Infect. Immun.
63:3609-3620[Abstract].
|
| 38.
|
Tan, M. W.,
S. Mahajan-Miklos, and F. M. Ausubel.
1999.
Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis.
Proc. Natl. Acad. Sci. USA
96:715-720[Abstract/Free Full Text].
|
| 39.
|
Tan, M. W.,
L. G. Rahme,
J. A. Sternberg,
R. G. Tompkins, and F. M. Ausubel.
1999.
Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors.
Proc. Natl. Acad. Sci. USA
96:2408-2413[Abstract/Free Full Text].
|
| 40.
|
Zuckman, D. M.,
J. B. Hung, and C. R. Roy.
1999.
Pore-forming activity is not sufficient for Legionella pneumophila phagosome trafficking and intracellular growth.
Mol. Microbiol.
32:990-1001[CrossRef][Medline].
|
Infection and Immunity, August 2001, p. 4782-4789, Vol. 69, No. 8
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.4782-4789.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Velazquez, F., Pfluger, K., Cases, I., De Eugenio, L. I., de Lorenzo, V.
(2007). The Phosphotransferase System Formed by PtsP, PtsO, and PtsN Proteins Controls Production of Polyhydroxyalkanoates in Pseudomonas putida. J. Bacteriol.
189: 4529-4533
[Abstract]
[Full Text]
-
Deutscher, J., Francke, C., Postma, P. W.
(2006). How Phosphotransferase System-Related Protein Phosphorylation Regulates Carbohydrate Metabolism in Bacteria. Microbiol. Mol. Biol. Rev.
70: 939-1031
[Abstract]
[Full Text]
-
Mavrodi, O. V., Mavrodi, D. V., Weller, D. M., Thomashow, L. S.
(2006). Role of ptsP, orfT, and sss Recombinase Genes in Root Colonization by Pseudomonas fluorescens Q8r1-96. Appl. Environ. Microbiol.
72: 7111-7122
[Abstract]
[Full Text]
-
Higa, F., Akamine, M., Haranaga, S., Tohyama, M., Shinzato, T., Tateyama, M., Koide, M., Saito, A., Fujita, J.
(2005). In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species. J Antimicrob Chemother
56: 1053-1057
[Abstract]
[Full Text]
-
Miyake, M., Watanabe, T., Koike, H., Molmeret, M., Imai, Y., Abu Kwaik, Y.
(2005). Characterization of Legionella pneumophila pmiA, a Gene Essential for Infectivity of Protozoa and Macrophages. Infect. Immun.
73: 6272-6282
[Abstract]
[Full Text]
-
Edelstein, P. H., Hu, B., Shinzato, T., Edelstein, M. A. C., Xu, W., Bessman, M. J.
(2005). Legionella pneumophila NudA Is a Nudix Hydrolase and Virulence Factor. Infect. Immun.
73: 6567-6576
[Abstract]
[Full Text]
-
Ismail, T. M., Hart, C. A., McLennan, A. G.
(2003). Regulation of Dinucleoside Polyphosphate Pools by the YgdP and ApaH Hydrolases Is Essential for the Ability of Salmonella enterica serovar Typhimurium to Invade Cultured Mammalian Cells. J. Biol. Chem.
278: 32602-32607
[Abstract]
[Full Text]
-
Edelstein, P. H., Hu, B., Higa, F., Edelstein, M. A. C.
(2003). lvgA, a Novel Legionella pneumophila Virulence Factor. Infect. Immun.
71: 2394-2403
[Abstract]
[Full Text]
-
Ewann, F., Jackson, M., Pethe, K., Cooper, A., Mielcarek, N., Ensergueix, D., Gicquel, B., Locht, C., Supply, P.
(2002). Transient Requirement of the PrrA-PrrB Two-Component System for Early Intracellular Multiplication of Mycobacterium tuberculosis. Infect. Immun.
70: 2256-2263
[Abstract]
[Full Text]